Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Differential splicing of KLK5 and KLK7 in epithelial ovarian cancer produces novel variants with potential as cancer biomarkers.

Clinical cancer research : an official journal of the American Association for Cancer Research - 1 May 2003

Dong Ying, Kaushal Aneel, Brattsand Maria, Nicklin Jim, Clements Judith A

Abstract excerpt

PURPOSE: The wild-type or variant mRNAs of several kallikrein (KLK) genes, such as KLK4, are highly expressed in ovarian carcinomas and may have potential as tumor markers. Two of these KLK genes (KLK5 and KLK7) and their proteins (hK5 and hK7) were first identified in the skin epidermis, where hK5 may be the physiological activator of hK7. The purpose of this study was to reexamine the expression of KLK5/hK5 and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 3' Untranslated Regions
Share to 5' Untranslated Regions

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Adenocarcinoma, Clear Cell

Share to Carcinoma, Endometrioid

Share to Cystadenocarcinoma, Serous

Share to Kallikreins

Share to Serine Endopeptidases

Source

Identifiers

PMID: 12738725

Genes

KLK5
KLK7
KLK4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Differential splicing of KLK5 and KLK7 in epithelial ovarian cancer produces novel variants with potential as cancer biomarkers.PMID 12738725Read ↗

Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas.Semantic proximity Read ↗

Molecular cloning of novel transcripts of human kallikrein-related peptidases 5, 6, 7, 8 and 9 (KLK5 – KLK9), using Next-generation sequencingSemantic proximity Read ↗

Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancerSemantic proximity Read ↗

Kallikrein-related peptidases represent attractive therapeutic targets for ovarian cancerSemantic proximity Read ↗

Identification of new splice variants and differential expression of the human kallikrein 10 gene, a candidate cancer biomarker.Semantic proximity Read ↗

Kallikrein-related peptidase (KLK) family mRNA variants and protein isoforms in hormone-related cancers: do they have a function?Semantic proximity Read ↗

Multiple kallikrein (KLK 5, 7, 8, and 10) expression in squamous cell carcinoma of the oral cavity.Semantic proximity Read ↗

Human tissue kallikreins and testicular cancerSemantic proximity Read ↗

Overexpression of the human tissue kallikrein genes KLK4, 5, 6, and 7 increases the malignant phenotype of ovarian cancer cellsSemantic proximity Read ↗

Kallikrein-related peptidase 10 (KLK10) expression and single nucleotide polymorphisms in ovarian cancer survival.Semantic proximity Read ↗

Expression analysis of the human kallikrein 7 (KLK7) in breast tumors: a new potential biomarker for prognosis of breast carcinomaSemantic proximity Read ↗

KLK5 and KLK7, two members of the human tissue kallikrein family, are differentially expressed in lung cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.